DOR Insider Trading Activity and SEC Form 4 Filings
DOR insider trading summary
No open-market insider purchases or sales of Dor Biopharma Inc (DOR) have been reported on SEC Form 4 in the past 12 months.
Latest DOR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 9, 2007 | Evan Myrianthopoulos | Chief Financial Officer | Buy | $25K (53,191 @ $0.47) |
| Feb 9, 2007 | Steve H Kanzer | Director | Buy | $100K (212,766 @ $0.47) |
| Feb 9, 2007 | James Clavijo | Controller/Treasurer | Buy | $25K (53,191 @ $0.47) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.